
A home self-imaging device can provide ophthalmologists with actionable insight between office visits for AMD

A home self-imaging device can provide ophthalmologists with actionable insight between office visits for AMD

This initiative is supported by a $5 million grant from the Knights Templar Eye Foundation.

Non-invasive, painless laser can reduce risk of vision loss

A large study performed in Canada analyzed data and found that patients are at higher risk of multiple possible complications after cataract surgery.

The subretinal drusenoid deposits may serve as a biomarker of serious heart disease.

The authors assessed whether a new diagnosis of dry eye increases the risk of developing depression, anxiety, fibromyalgia, and chronic fatigue compared to those without dry eye.

While anxiety and depression may cause vision loss, physicians can offer hope

The Center, which was launched in 2023, will now be named The Barry Family Center for Ophthalmic Artificial Intelligence and Human Health.

The American Academy of Ophthalmology 2024 annual meeting features key lectures and award sessions, highlighting advancements in ophthalmology from leading experts across the field.


Related macular dystrophies include Sorsby’s fundus dystrophy, Doyne honeycomb macular dystrophy, and autosomal dominant radial drusen.

Changes associated with Alzheimer's disease extend beyond the brain.

The investigators undertook a study in which they retrospectively evaluated the presence and amount of small HRF in the eyes of patients with different macular atrophic phenotypes.

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be involved in ocular growth


Investigadores brasileños preocupados por la aparición de metástasis oculares realizaron un estudio retrospectivo y descubrieron que la frecuencia de metástasis oculares era relativamente baja, según su primer autor Matheus Senna Pereira Ogata, MD.

This research builds on previous experience that stimulating nicotinic receptors can inhibit experimental myopia

TEPEZZA is the first and only medicine approved in Japan to treat active TED.




CVD could impact physicians' ability to identify choroidal melanoma from choroidal nevus.

Cutting-edge approaches for MDs and ODs

Option provides surgeons with flexibility and creativity.

CHG is an effective alternative antiseptic to PI and the cost is outweighed by increased patient comfort.

Aflibercept biosimilars have cleared several hurdles on their way to marketplace


Push to identify biomarkers for earlier diagnosis, new therapeutic targets.

Identifying all genetic culprits may improve diagnostics and prognoses.

The drop improves vision by breaking up degraded protein complexes that cause lens clouding